A detailed history of Sei Investments CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 393,481 shares of ADMA stock, worth $4.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
393,481
Previous 142,556 176.02%
Holding current value
$4.41 Million
Previous $644,000 303.11%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$4.4 - $6.74 $1.1 Million - $1.69 Million
250,925 Added 176.02%
393,481 $2.6 Million
Q4 2023

Feb 14, 2024

BUY
$3.08 - $4.52 $145,249 - $213,158
47,159 Added 49.43%
142,556 $644,000
Q3 2023

Nov 14, 2023

SELL
$3.47 - $4.61 $3,445 - $4,577
-993 Reduced 1.03%
95,397 $341,000
Q1 2023

May 12, 2023

SELL
$3.01 - $3.87 $36,893 - $47,434
-12,257 Reduced 11.28%
96,390 $319,000
Q4 2022

Feb 10, 2023

BUY
$2.47 - $3.88 $268,358 - $421,550
108,647 New
108,647 $421,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.2B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.